Ciclopirox microbiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
==Microbiology==
==Microbiology==


The coverage for the following causes:
The coverage for the following fungal organisms:


*'''[[Trichophyton rubrum]]
*'''[[Trichophyton rubrum]]


*'''[[Trichophyton mentagrophytes]]
*'''[[Trichophyton]] mentagrophytes


*'''[[Epidermophyton floccosum]]
*'''[[Epidermophyton]] floccosum


*'''[[Microsporum canis]]
*'''[[Microsporum]] canis


*'''[[Candida albicans]]
*'''[[Candida albicans]]

Revision as of 01:08, 6 January 2014

Ciclopirox
Ciclodan®FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Microbiology

The coverage for the following fungal organisms:

[1]

References

  1. "CICLODAN (CICLOPIROX OLAMINE) CREAM CICLODAN (CICLOPIROX OLAMINE) KIT [MEDIMETRIKS PHARMACEUTICALS, INC.]".

Adapted from the FDA Package Insert.